Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Other Working Capital Changes (2016 - 2023)

Historic Other Working Capital Changes for Aptevo Therapeutics (APVO) over the last 9 years, with Q3 2023 value amounting to $342000.0.

  • Aptevo Therapeutics' Other Working Capital Changes fell 4466.02% to $342000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was -$24000.0, marking a year-over-year increase of 9782.81%. This contributed to the annual value of -$153000.0 for FY2023, which is 5690.14% up from last year.
  • Latest data reveals that Aptevo Therapeutics reported Other Working Capital Changes of $342000.0 as of Q3 2023, which was down 4466.02% from -$1.5 million recorded in Q2 2023.
  • Over the past 5 years, Aptevo Therapeutics' Other Working Capital Changes peaked at $2.5 million during Q4 2019, and registered a low of -$2.4 million during Q3 2019.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$121000.0 (2019), whereas its average is -$115263.2.
  • As far as peak fluctuations go, Aptevo Therapeutics' Other Working Capital Changes crashed by 25801.47% in 2019, and later soared by 119834.71% in 2020.
  • Quarter analysis of 5 years shows Aptevo Therapeutics' Other Working Capital Changes stood at $2.5 million in 2019, then tumbled by 73.47% to $657000.0 in 2020, then crashed by 172.3% to -$475000.0 in 2021, then surged by 157.89% to $275000.0 in 2022, then increased by 24.36% to $342000.0 in 2023.
  • Its Other Working Capital Changes was $342000.0 in Q3 2023, compared to -$1.5 million in Q2 2023 and $841000.0 in Q1 2023.